Abstract
Purpose
The state of Puebla has the social marginalization and ecological conditions for the transmission of infectious agents to be effective. Until a few years ago, the state of Puebla was considered non-endemic to the presence of Trypanosoma cruzi as there are no official reports of chronic cases. The objective of this work was to carry out a preliminary study on the prevalence of anti-T. cruzi antibodies in rural areas of the Huatlatlauca municipality in the Mixtec sierra of the state of Puebla.
Methods
A total of 196 serum samples from 12 rural localities were tested by using four tests: two enzyme-linked immunosorbent assays, an xenodiagnoses and PCR assay.
Results
Overall, 28 (14.2%) of 196 samples were positive for T. cruzi by ≥ 2 tests (95% CI 6.6–20.8%). Our results suggested that the municipality of Huatlatlauca in the Mixteca Sierra of the state of Puebla is an area with endemic potential for the disease with a high prevalence rate in the adult population and with cases in newborns, these high transmission rates are probably associated with problems of congenital and vector transmission.
Conclusion
Additional studies should be conducted to generate adequate campaigns for the control of Chagas disease in this area.
Similar content being viewed by others
References
Alvarenga NJ, Brofen E (1997) Metaciclogênese do Trypanosoma cruzi como parâmetro de interação do parasita com o triatomíneo vetor. Rev Soc Bras Med Trop 30:247–250
Barbu C, Dumonteil E, Gourbière S (2010) Characterization of the dispersal of non-domiciliated Triatoma dimidiata through the selection of spatially explicit models. PLOS Negl Trop Dis 4(8):e777. https://doi.org/10.1371/journal.pntd.0000777
Becerril M, Angeles-Pérez A, Noguez-García J, lmbert-Palafox J (2010) Riesgo de transmisión de trypanosoma cruzi en el municipio de Metztitlán, estado de Hidalgo, México, mediante la caracterización de unidades domiciliares y sus índices entomológicos. Neotrop Entomol 39(5):810–817
Briceño-León R (2009) La enfermedad de Chagas en las Américas: una perspectiva de ecosalud. Cadernos de Saúde Pública 25(Suppl 2):S71–S82
Carabarin-Lima A, González-Vázquez MC, Rodríguez-Morales O, Baylón-Pacheco L, Rosales-Encina JL, Reyes-López PA et al (2013) Chagas disease (American trypanosomiasis) in Mexico: an update. Acta Trop 127(2):126–135. https://doi.org/10.1016/j.actatropica.2013.04.007
Costa de Albuquerque MA, Dias DM, Vieira LT, Lima CA, da Silva AM (2017) Mortality trends for neglected tropical diseases in the state of Sergipe, Brazil, 1980–2013. Infect Dis Poverty 6(1):20. https://doi.org/10.1186/s40249-016-0232-8
Cruz-Reyes A, Pickering-Lopez JM (2006) Chagas disease in Mexico: an analysis of geographical distribution during the past 76 years—a review. Memórias do Instituto Oswaldo Cruz 101:345–354
Dumonteil E, Gourbie`re S, Barrera-Perez M, Rodriguez-Felix E, Ruiz-Piña H, Baños-Lopez O et al (2002) Geographic distribution of Triatoma dimidiata and transmission dynamics of Trypanosoma cruzi in the Yucatan peninsula of Mexico. Am J Trop Med Hyg 67:176–183
Eisenstein M (2016) Disease: poverty and pathogens. Nature 531(7594):S61–S63. https://doi.org/10.1038/531S61a
García-Jordán N, Berrizbeitia M, Rodríguez J, Concepción JL, Cáceres A, Quiñones W (2017) Seroprevalence of Trypanosoma cruzi infection in the rural population of Sucre state, Venezuela. Cadernos de Saúde Pública. 33(10):e00050216
Guzmán-Gómez D, López-Monteon A, Lagunes-Castro MS, Álvarez-Martínez C, Hernández-Lutzon MJ, Dumonteil E et al (2015) Highly discordant serology against Trypanosoma cruzi in central Veracruz, Mexico: role of the antigen used for diagnostic. Parasit Vectors 17(8):466. https://doi.org/10.1186/s13071-015-1072-2
Manne JM, Snively CS, Ramsey JM, Salgado MO, Barnighausen T, Reich MR (2013) Barriers to treatment access for Chagas disease in Mexico. PLOS Negl Trop Dis 7:e2488. https://doi.org/10.1371/journal.pntd.0002488
Mischler P, Kearney M, McCarroll JC, Scholte RG, Vounatsou P, Malone JB (2012) Environmental and socio-economic risk modelling for Chagas disease in Bolivia. Geospatial Health 6(3):S59–S66
Monteón VM, Reyes-López PA, Sosa-Palacio A, León-Tello G, Martínez-Murguía J, Sosa-Jurado F (2005) Heterogeneous distribution of the prevalence of anti-Trypanosoma cruzi antibodies among blood donors in the state of Puebla, Mexico. Salud Pública de Mexico 47(2):116–125
Newton-Sánchez OA, Espinoza-Gómez F, Melnikov V, Delgado-Enciso I, Rojas-Larios F, Dumonteil E et al (2017) Seroprevalence of Trypanosoma cruzi (TC) and risk factors in Colima, Mexico. Gaceta Medica de Mexico 153(2):179–184
Ramos-Ligonio A, López-Monteon A, Guzmán-Gómez D, Rosales-Encina JL, Limón-Flores Y, Dumonteil E (2010) Identification of a hyperendemic area for Trypanosoma cruzi infection in central Veracruz, Mexico. Am J Trop Med Hyg 83(1):164–170. https://doi.org/10.4269/ajtmh.2010.09-0677
Ramos-Ligonio A, Ramirez-Sanchez ME, Gonzalez-Hernandez JC, Rosales-Encina JL, Lopez-Monteon A (2006) Prevalencia de anticuerpos contra Trypanosoma cruzi en donadores de sangre del IMSS, Orizaba, Veracruz, Mexico. Salud Publica Mex 48:13–21
Sánchez-Guillén MC, Barnabé C, Guégan JF, Tibayrenc M, Velásquez-Rojas M, Martínez-Munguía J et al (2002) High prevalence anti-Trypanosoma cruzi antibodies, among blood donors in the state of Puebla, a non-endemic area of Mexico. Memórias do Instituto Oswaldo Cruz 97(7):947–952
Sánchez-Guillén MC, López-Colombo A, Ordóñez-Toquero G, Gomez-Albino I, Ramos-Jimenez J, Torres-Rasgado E et al (2006) Clinical forms of Trypanosoma cruzi infected individuals in the chronic phase of Chagas disease in Puebla, Mexico. Memórias do Instituto Oswaldo Cruz. 101(7):733–740
Sandoval-Ruiz CA, Zumaquero-Rios JL, Rojas-Soto O (2008) Predicting geographic and ecological distributions of triatomine species in the southern Mexican state of Puebla using ecological niche modeling. J Med Entomol 45(3):540–546
Secretaría de Salud (2014b) Prevención y control de la enfermedad de Chagas: Programa sectorial de salud 2013–2018, México, recuperado. http://www.cenaprece.salud.gob.mx/descargas/pdf/PAE_PrevencionControlEnfermedadChagas2013_2018.pdf. Accessed 10 Sept 2018
Secretaría de Salud (2014c) Subsecretaría de Prevención y Promoción de la Salud. CENAPRECE. Manual de diagnóstico y tratamiento de la enfermedad de chagas. 2014, México recuperado. https://www.gob.mx/cms/uploads/attachment/file/235962/ManualDX_TxEnfermedadCHAGAS2015.pdf. Accessed 10 Sept 2018
SEDESOL (2017) Subsecretaría de prospectiva, planeación y evaluación, informe anual sobre la situación de pobreza y rezago social. Recuperado https://www.gob.mx/cms/uploads/attachment/file/38233/Puebla_070.pdf. Accessed 15 Oct 2018
Solís H, De Carvalho E, Ferreira C, Casanova C, Huamán A, Mendoza V (2003) Contribución al estudio de la epidemiología de la enfermedad de Chagas en tres localidades de la zona sur del Perú. Anales de la Facultad de Medicina 64(4):223–227
Souza RM, Amato Neto V (2012) Discrepancies and consequences of indirect hemagglutination, indirect immunofluorescence and ELISA tests for the diagnosis of Chagas disease. Revista do Instituto de Medicina Tropical de São Paulo 54(3):141–143
Tarleton RL, Gurtler RE, Urbina JA, Ramsey J, Viotti R (2014) Chagas disease and the London declaration on neglected tropical diseases. PLOS Negl Trop Dis 8(10):e3219. https://doi.org/10.1371/journal.pntd.0003219
WHO (2017) Chagas disease (American trypanosomiasis) descriptive note March 2017. http://www.who.int/mediacentre/factsheets/fs340/es/. Accessed 13 Aug 2018
Acknowledgements
The authors would like to thank the vice-rectory of research and post-grade studies of the Meritorious Autonomous University of Puebla.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors have no conflict of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zumaquero-Ríos, L., Sarracent-Pérez, J., Sandoval-Ruiz, C. et al. Presence of Seropositive Patients to Trypanosoma cruzi in a Municipality of the Mixtec Sierra of the State of Puebla: A Preliminary Study. Acta Parasit. 65, 19–26 (2020). https://doi.org/10.2478/s11686-019-00118-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11686-019-00118-9